Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.
about
Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporterIntelligent design: combination therapy with oncolytic virusesThe ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implicationsVesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerThe sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapiesThe use of the NIS reporter gene for optimizing oncolytic virotherapySodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancerAttenuation of vesicular stomatitis virus encephalitis through microRNA targeting.Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapySafety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primatesNormalisation to blood activity is required for the accurate quantification of Na/I symporter ectopic expression by SPECT/CT in individual subjects.Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesisEpidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene deliveryPinhole micro-SPECT/CT for noninvasive monitoring and quantitation of oncolytic virus dispersion and percent infection in solid tumors.Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.Curative one-shot systemic virotherapy in murine myeloma.Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy.Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sites.Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia.Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic VirusesInduction of antiviral genes by the tumor microenvironment confers resistance to virotherapyHSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapyCell carriers to deliver oncolytic viruses to sites of myeloma tumor growth.Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways.Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer.Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neckThe use of molecular imaging of gene expression by radiotracers in gene therapy.Replicating viral vectors for cancer therapy: strategies to synergize with host immune responses.Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications.Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV.Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.
P2860
Q21134124-B6038C8D-949D-47E9-AE2F-83F4A908BEEEQ24628227-88A5DCEA-A23C-4AC3-9CC1-9E9F49FBAEE9Q27002660-97E93BDD-0610-4C7D-889A-310CE27B8C52Q27021839-C6F6199D-51FD-41C1-8462-2064187C1698Q27023157-893489CC-0C31-4473-A62D-4AEAD0041228Q28083534-F98A14EE-6491-4649-910B-55C35E3057AFQ33603806-BA0C92A3-2B32-42B9-B618-A2947CCAEFB2Q33614368-18E35F86-31B6-4BDD-984D-BC77A02D3FDFQ33690729-A3CDCBC5-107A-4BD0-8325-4541CCB1A52CQ33832168-8FF507C7-1FCD-44BA-8B70-ADAF6BBDC7D1Q34217690-45BD4632-5DD9-4F58-991A-50095F59BF06Q34303955-688B5DB3-5A68-43AD-B8B2-998CF8DF7D5FQ34411693-65486683-644F-4943-8748-38ADA10F8B70Q34757186-5AE8C56C-CD86-4353-AE31-049CF49A54BDQ35238289-6B01478B-12A1-4FD3-A681-2690007E8A8CQ35415103-F879A1F9-05A4-4C2D-9B43-CC1ADF811AEFQ35612571-5B4E21F3-A4EC-4D8A-8BF4-F6907B6388A5Q36049446-336F8049-E3BC-4DA3-B5E8-DC2398121F48Q36128415-40AA6084-E0D2-45F9-BFB8-2983A58505DEQ36139716-778FD203-73D0-43A5-B803-DD7845A5288CQ36664219-588DDDC9-9BB5-476F-84CE-2C270A89C842Q36667968-36F2B815-AF19-4705-A0FA-CCD26CA2569CQ36700481-7A6F389F-6041-401D-BE4F-23E08B7F2CC8Q36751597-0C1C69CA-D6A9-44FD-ADF5-D3F78B2E7BCEQ36756897-1248B1F6-3638-4EA3-8DD3-5E3C9D0D62A4Q37076976-42FE5EB2-8C7C-4DA7-82CB-3124649EC0DAQ37104963-C47A013D-DDC1-4E14-A887-901C9780AA44Q37115384-855D5634-5AFC-421E-A360-1AA5D93A2A14Q37123143-95E9871F-EC08-4473-8A81-8045D2F20A89Q37373616-EF1026AA-B0B6-4080-9B7C-66544C139492Q37564490-AA85F265-9087-4234-92B6-E41C79D7F55BQ37625385-0C1557FC-013F-44F0-B526-541E73B38143Q37672599-3BD48475-8E97-40D1-8047-BB16B60B587FQ37884052-36BEA0EF-DF56-448F-B7F3-AEF5C858678FQ37933439-6E195074-572F-480B-86B8-ECDB589AEB4DQ37940343-85311D9B-D052-4E08-8949-7B4615257649Q37977063-8929F1E1-1C3F-456E-A098-47F29789F47AQ38003153-4651C435-B445-43BF-BB7A-EF0C3FE1F638Q38780400-92B8034E-830B-40A3-9056-6897C5F67927Q38799217-93EF3175-B07D-4B90-BA87-D2D969308D07
P2860
Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Radioiodide imaging and radiov ...... sodium iodide symporter gene.
@ast
Radioiodide imaging and radiov ...... sodium iodide symporter gene.
@en
type
label
Radioiodide imaging and radiov ...... sodium iodide symporter gene.
@ast
Radioiodide imaging and radiov ...... sodium iodide symporter gene.
@en
prefLabel
Radioiodide imaging and radiov ...... sodium iodide symporter gene.
@ast
Radioiodide imaging and radiov ...... sodium iodide symporter gene.
@en
P2093
P2860
P1433
P1476
Radioiodide imaging and radiov ...... sodium iodide symporter gene.
@en
P2093
Anthony T Power
Apollina Goel
Kelly L Classic
Shruthi Naik
Stephanie K Carlson
Suzanne Greiner
P2860
P304
P356
10.1182/BLOOD-2007-01-065573
P407
P577
2007-05-21T00:00:00Z